MOTT DAVID M Insider Trading
Get the latest insider transactions of MOTT DAVID M. MOTT DAVID M is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM). Discover the current value of MOTT DAVID M shares.
Address: 35 WEST WATKINS MILL ROAD GAITHERSBURG 20878MD
MOTT DAVID M is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
MEDI | MEDIMMUNE INC /DE | Vice Chairman and CEO | 0 | 0.00 |
TSRO | TESARO, Inc. | Director | 0 | 0.00 |
ARDX | ARDELYX, INC. | Director | 417,284 | 4,610,988.20 |
EPZM | Epizyme, Inc. | Director | 153,627 | 1,851,205.35 |
SYBX | SYNLOGIC, INC. | 10% Owner | 4,228,940 | 9,303,668.00 |
CERC | Cerecor Inc. | 10% Owner | 594,245 | 493,223.35 |
ILIU | INTERLEUKIN GENETICS INC | 10% Owner | 55,418,811 | 5,541,881.10 |
ADAP | Adaptimmune Therapeutics PLC | Director | 19,500,000 | 88,335,000.00 |
ROKA | Sorrento Tech, Inc. | 10% Owner | 0 | 0.00 |
RARX | Ra Pharmaceuticals, Inc. | 10% Owner | 80,658 | 1,465,555.86 |
TCON | Tracon Pharmaceuticals, Inc. | 10% Owner | 3,466,003 | 17,156,714.85 |
AKAO | Achaogen, Inc. | 10% Owner | 5,215,128 | 98,305,162.80 |
MULE | MULESOFT, INC | 10% Owner | 12,679,970 | |
AVEO | AVEO PHARMACEUTICALS, INC. | 10% Owner | 25,243,865 | 15,398,757.65 |
APPN | APPIAN CORP | 10% Owner | 2,724,202 | |
MRSN | Mersana Therapeutics, Inc. | Director | 9,109 | |
RYTM | RHYTHM PHARMACEUTICALS, INC. | 10% Owner | 1,432,248 | |
CRCM | Care.com Inc | 10% Owner | 2,256,013 | 21,071,161.42 |
ABIO | ARCA biopharma, Inc. | 10% Owner | 0 | 0.00 |
CASC | Cascadian Therapeutics, Inc. | 10% Owner | 0 | 0.00 |
SURF | Surface Oncology, Inc. | 10% Owner | 3,179,544 | |
ESTC | Elastic N.V. | 10% Owner | 4,155,995 | |
NITE | Nightstar Therapeutics plc | Director | 0 | |
TRVI | Trevi Therapeutics, Inc. | 10% Owner | 1,938,562 | |
RGLS | Regulus Therapeutics Inc. | 10% Owner | 2,052,454 | 2,873,435.60 |
GNCA | GENOCEA BIOSCIENCES, INC. | 10% Owner | 7,225,676 | 32,587,798.76 |
MIRM | Mirum Pharmaceuticals, Inc. | 10% Owner | 3,736,243 | |
IMRA | IMARA Inc. | Director | 0 | |
NVAX | NOVAVAX INC | Director | 0 | 0.00 |
Insider Trading Transactions of MOTT DAVID M
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | 179.89 | 1,300 | 233,857 | 1,300 |
Jun 22 2021 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | 0.00 | 700 | 0 | 700 |
Apr 01 2021 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 8.71 | 2,727 | 23,752 | 153,627 |
Jan 20 2021 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 21.09 | 4,528 | 95,496 | 4,528 |
Jan 05 2021 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 10.86 | 2,158 | 23,436 | 88,183 |
Dec 15 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 1,096 | 0 | 9,109 |
Dec 15 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 486 | 0 | 9,595 |
Dec 10 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 5.89 | 170,000 | 1,000,841 | 417,284 |
Nov 12 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 1,106 | 0 | 4,296 |
Nov 12 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 496 | 0 | 4,792 |
Nov 12 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 496 | 0 | 5,288 |
Nov 12 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 1,112 | 0 | 6,400 |
Oct 01 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 11.93 | 1,965 | 23,442 | 86,025 |
Sep 28 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | 12.66 | 50,000 | 633,000 | 50,000 |
Jul 01 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 16.06 | 1,459 | 23,432 | 84,060 |
Jul 01 2020 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Option Exercise | 1.67 | 226,753 | 378,678 | 226,753 |
Jun 29 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 22.90 | 9,200 | 210,680 | 9,200 |
Jun 26 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 6.75 | 72,598 | 489,862 | 178,911 |
Jun 26 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 6.96 | 68,373 | 476,040 | 247,284 |
Jun 26 2020 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | 83.54 | 4,400 | 367,576 | 4,400 |
Jun 26 2020 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | 83.54 | 4,400 | 367,576 | 4,400 |
Jun 26 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 16.03 | 62,019 | 994,165 | 82,601 |
Jun 24 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 6.75 | 4,673 | 31,525 | 106,313 |
Jun 22 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 0.00 | 67,662 | 0 | 106,959 |
Jun 18 2020 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | 52.15 | 8,000 | 417,200 | 8,000 |
Jun 11 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 0.00 | 12,995 | 0 | 100,561 |
Jun 11 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 0.00 | 1,079 | 0 | 101,640 |
Jun 11 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Option Exercise | 7.31 | 23,500 | 171,785 | 23,500 |
Jun 11 2020 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Option Exercise | 7.31 | 75,000 | 548,250 | 75,000 |
Jun 02 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | 17.55 | 14,013 | 245,928 | 14,013 |
Apr 13 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 2,197 | 0 | 2,197 |
Apr 13 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 993 | 0 | 3,190 |
Apr 09 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 5.59 | 538,599 | 3,010,768 | 538,599 |
Apr 02 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 15.51 | 1,512 | 23,451 | 20,582 |
Mar 16 2020 | IMRA | IMARA Inc. | MOTT DAVID M | Director | Option Exercise | 16.00 | 15,457 | 247,312 | 15,457 |
Jan 28 2020 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 |
Jan 03 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 5.36 | 19,713 | 105,662 | 19,713 |
Jan 03 2020 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 5.36 | 19,713 | 105,662 | 19,713 |
Dec 26 2019 | RGLS | Regulus Therapeutics Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.67 | 9,009,000 | 5,999,994 | 9,009,000 |
Dec 26 2019 | RGLS | Regulus Therapeutics Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 900,900 | 0 | 900,900 |
Dec 09 2019 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 6.25 | 400,000 | 2,500,000 | 3,482,186 |
Oct 02 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 10.32 | 2,271 | 23,437 | 18,118 |
Jul 24 2019 | MIRM | Mirum Pharmaceuticals, In ... | MOTT DAVID M | 10% Owner | Buy | 0.00 | 3,736,243 | 0 | 3,736,243 |
Jul 24 2019 | MIRM | Mirum Pharmaceuticals, In ... | MOTT DAVID M | 10% Owner | Buy | 15.00 | 450,000 | 6,750,000 | 4,186,243 |
Jul 24 2019 | MIRM | Mirum Pharmaceuticals, In ... | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 29,889,945 | 0 | 0 |
Jul 03 2019 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Option Exercise | 0.61 | 350,947 | 214,078 | 350,947 |
Jun 28 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | 12.43 | 52,473 | 652,134 | 0 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | 0.00 | 2,500,000 | 0 | 3,971,018 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 0.00 | 767,500 | 0 | 767,500 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | 0.00 | 767,500 | 0 | 0 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 0.00 | 38,646 | 0 | 39,297 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 0.00 | 157,417 | 0 | 157,417 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | 13.31 | 52,472 | 698,649 | 104,945 |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | 12.85 | 52,472 | 674,176 | 52,473 |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCES, INC. | MOTT DAVID M | 10% Owner | Buy | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCES, INC. | MOTT DAVID M | 10% Owner | Buy | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 |
Jun 17 2019 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 0.00 | 32,846 | 0 | 87,566 |
Jun 17 2019 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Option Exercise | 2.74 | 50,000 | 137,000 | 50,000 |
Jun 11 2019 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 4.31 | 25,000 | 107,750 | 25,000 |
Jun 07 2019 | NITE | Nightstar Therapeutics pl ... | MOTT DAVID M | Director | Sell | 25.50 | 6,662,532 | 169,894,566 | 0 |
Jun 07 2019 | NITE | Nightstar Therapeutics pl ... | MOTT DAVID M | Director | Option Exercise | 12.27 | 36,400 | 446,628 | 0 |
Jun 07 2019 | NITE | Nightstar Therapeutics pl ... | MOTT DAVID M | Director | Option Exercise | 13.57 | 21,000 | 284,970 | 0 |
Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 12.39 | 1,891 | 23,429 | 13,979 |
Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | 13.74 | 17,633 | 242,277 | 17,633 |
May 13 2019 | TRVI | Trevi Therapeutics, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 1,938,562 | 0 | 1,938,562 |
May 13 2019 | TRVI | Trevi Therapeutics, Inc. | MOTT DAVID M | 10% Owner | Buy | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 |
May 13 2019 | TRVI | Trevi Therapeutics, Inc. | MOTT DAVID M | 10% Owner | Buy | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 |
May 13 2019 | TRVI | Trevi Therapeutics, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 17,099,315 | 0 | 0 |
May 09 2019 | RGLS | Regulus Therapeutics Inc. | MOTT DAVID M | 10% Owner | Buy | 1.08 | 1,136,704 | 1,227,640 | 2,052,454 |
May 09 2019 | RGLS | Regulus Therapeutics Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 1.08 | 3,703,704 | 4,000,000 | 3,703,704 |
May 09 2019 | RGLS | Regulus Therapeutics Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 256,700 | 0 | 256,700 |
Apr 08 2019 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.14 | 4,347,827 | 4,956,523 | 25,243,865 |
Apr 08 2019 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Option Exercise | 1.25 | 4,347,827 | 5,434,784 | 4,347,827 |
Mar 06 2019 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 4.00 | 3,750,000 | 15,000,000 | 11,890,138 |
Jan 29 2019 | NITE | Nightstar Therapeutics pl ... | MOTT DAVID M | Director | Option Exercise | 13.57 | 21,000 | 284,970 | 21,000 |
Jan 29 2019 | NITE | Nightstar Therapeutics pl ... | MOTT DAVID M | Director | Option Exercise | 13.57 | 21,000 | 284,970 | 21,000 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Sell | 75.00 | 15,362 | 1,152,150 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Sell | 75.00 | 9,681,038 | 726,077,850 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Sell | 75.00 | 739,517 | 55,463,775 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Sell | 75.00 | 1,333 | 99,975 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 0.00 | 4,052 | 0 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 46.22 | 10,000 | 462,200 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 26.36 | 10,000 | 263,600 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 60.77 | 10,000 | 607,700 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 47.27 | 12,000 | 567,240 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 149.22 | 12,000 | 1,790,640 | 0 |
Jan 22 2019 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 46.89 | 7,290 | 341,828 | 0 |
Jan 04 2019 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 4.31 | 25,292 | 109,009 | 25,292 |
Dec 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.63 | 200,000 | 326,060 | 20,596,038 |
Dec 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.49 | 300,000 | 448,380 | 20,896,038 |
Dec 12 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.98 | 61,200 | 121,084 | 20,396,038 |
Dec 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.99 | 27,300 | 54,414 | 20,191,738 |
Dec 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.98 | 117,100 | 232,362 | 20,308,838 |
Dec 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.98 | 26,000 | 51,576 | 20,334,838 |
Nov 30 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.99 | 24,500 | 48,824 | 20,092,538 |
Nov 30 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.98 | 71,900 | 142,067 | 20,164,438 |
Nov 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.98 | 170,000 | 336,107 | 20,068,038 |
Nov 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.98 | 170,000 | 336,107 | 20,068,038 |
Nov 19 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.86 | 340,000 | 631,958 | 19,038,038 |
Nov 19 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.86 | 350,000 | 649,355 | 19,388,038 |
Nov 19 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.88 | 510,000 | 956,658 | 19,898,038 |
Oct 10 2018 | ESTC | Elastic N.V. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 4,155,995 | 0 | 4,155,995 |
Oct 10 2018 | ESTC | Elastic N.V. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 1,528,117 | 0 | 1,528,117 |
Oct 10 2018 | ESTC | Elastic N.V. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 4,155,995 | 0 | 0 |
Oct 10 2018 | ESTC | Elastic N.V. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 1,528,117 | 0 | 0 |
Oct 05 2018 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 9.00 | 416,667 | 3,750,003 | 6,471,018 |
Sep 21 2018 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 12.27 | 10,000 | 122,700 | 10,000 |
Sep 10 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 |
Sep 10 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 |
Aug 22 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.26 | 663,716 | 1,499,998 | 18,698,038 |
Jul 20 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 1.95 | 200,000 | 390,580 | 17,983,722 |
Jul 20 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.00 | 50,600 | 101,165 | 18,034,322 |
Jul 02 2018 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 13.55 | 6,088 | 82,492 | 12,088 |
Jun 28 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.15 | 5,295 | 11,384 | 17,596,592 |
Jun 28 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.10 | 187,130 | 392,692 | 17,783,722 |
Jun 26 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Option Exercise | 2.18 | 187,330 | 408,379 | 187,330 |
Jun 15 2018 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 0.00 | 20,843 | 0 | 54,720 |
Jun 15 2018 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Option Exercise | 4.03 | 15,000 | 60,450 | 15,000 |
Jun 05 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 0.00 | 2,537 | 0 | 15,362 |
Jun 05 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 46.89 | 7,209 | 338,030 | 7,209 |
Jun 05 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 0.00 | 4,052 | 0 | 4,052 |
May 31 2018 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | 17.00 | 12,500 | 212,500 | 12,500 |
May 30 2018 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 4.00 | 416,666 | 1,666,664 | 3,082,186 |
May 30 2018 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 4.00 | 416,667 | 1,666,668 | 3,082,186 |
May 30 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.15 | 275 | 591 | 17,591,297 |
May 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.13 | 184,179 | 391,436 | 17,538,722 |
May 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.14 | 20,100 | 42,928 | 17,558,822 |
May 21 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.14 | 32,200 | 69,059 | 17,591,022 |
May 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.13 | 70,873 | 151,250 | 17,354,543 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Buy | 0.00 | 12,679,970 | 0 | 12,679,970 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Sell | 0.00 | 12,679,970 | 0 | 0 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Buy | 0.00 | 2,576,939 | 0 | 2,576,939 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Sell | 0.00 | 2,576,939 | 0 | 0 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Buy | 0.00 | 858,978 | 0 | 858,978 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Sell | 0.00 | 858,978 | 0 | 0 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 12,679,970 | 0 | 0 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 2,576,939 | 0 | 0 |
May 09 2018 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 858,978 | 0 | 0 |
Apr 23 2018 | SURF | Surface Oncology, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 3,179,544 | 0 | 3,179,544 |
Apr 23 2018 | SURF | Surface Oncology, Inc. | MOTT DAVID M | 10% Owner | Buy | 15.00 | 133,333 | 1,999,995 | 3,312,877 |
Apr 23 2018 | SURF | Surface Oncology, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 6,995,000 | 0 | 0 |
Apr 23 2018 | SURF | Surface Oncology, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 3,179,544 | 0 | 3,179,544 |
Apr 23 2018 | SURF | Surface Oncology, Inc. | MOTT DAVID M | 10% Owner | Buy | 15.00 | 133,333 | 1,999,995 | 3,312,877 |
Apr 23 2018 | SURF | Surface Oncology, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 6,995,000 | 0 | 0 |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.24 | 685,676 | 1,536,943 | 17,048,370 |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.43 | 32,100 | 78,099 | 17,080,470 |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 2.46 | 203,200 | 499,994 | 17,283,670 |
Mar 28 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.90 | 571,164 | 1,087,553 | 73,978,672 |
Mar 28 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.92 | 6,000,000 | 11,500,200 | 79,978,672 |
Mar 27 2018 | TCON | Tracon Pharmaceuticals, I ... | MOTT DAVID M | 10% Owner | Buy | 2.70 | 707,964 | 1,911,503 | 3,466,003 |
Mar 27 2018 | TCON | Tracon Pharmaceuticals, I ... | MOTT DAVID M | 10% Owner | Option Exercise | 2.70 | 707,964 | 1,911,503 | 707,964 |
Mar 23 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.81 | 104,844 | 189,820 | 72,243,844 |
Mar 23 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.90 | 869,574 | 1,655,669 | 73,113,418 |
Mar 23 2018 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 1.95 | 294,090 | 572,358 | 73,407,508 |
Mar 13 2018 | CASC | Cascadian Therapeutics, I ... | MOTT DAVID M | 10% Owner | Sell | 0.00 | 10,882,574 | 0 | 0 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 54.32 | 26,304 | 1,428,875 | 9,590,988 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 55.01 | 6,399 | 352,005 | 9,597,387 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 56.66 | 4,080 | 231,174 | 9,601,467 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 57.34 | 17,859 | 1,024,114 | 9,619,326 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 58.28 | 30,321 | 1,767,153 | 9,649,647 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 59.15 | 1,600 | 94,634 | 9,651,247 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 59.76 | 17,248 | 1,030,813 | 9,668,495 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 59.82 | 12,634 | 755,708 | 9,681,129 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 54.32 | 6,575 | 357,165 | 717,004 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 55.01 | 1,600 | 88,015 | 718,604 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 56.66 | 1,020 | 57,794 | 719,624 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 57.34 | 4,465 | 256,043 | 724,089 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 58.28 | 7,557 | 440,433 | 731,646 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 59.15 | 400 | 23,658 | 732,046 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 59.76 | 4,311 | 257,643 | 736,357 |
Mar 06 2018 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 59.82 | 3,159 | 188,957 | 739,516 |
Feb 27 2018 | ABIO | ARCA biopharma, Inc. | MOTT DAVID M | 10% Owner | Sell | 0.50 | 1,460,209 | 731,273 | 0 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 2,724,202 | 0 | 2,724,202 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Sell | 0.00 | 2,724,202 | 0 | 0 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 27,242 | 0 | 27,242 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Sell | 0.00 | 27,242 | 0 | 0 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 13,621 | 0 | 13,621 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Sell | 0.00 | 13,621 | 0 | 0 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 8,949 | 0 | 8,949 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 1,352 | 0 | 1,352 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 4,946 | 0 | 13,895 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 679 | 0 | 2,031 |
Feb 15 2018 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 2,724,202 | 0 | 0 |
Jan 26 2018 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% Owner | Buy | 9.75 | 410,000 | 3,997,500 | 4,228,940 |
Jan 04 2018 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 17.39 | 6,611 | 114,965 | 6,611 |
Nov 27 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 569,620 | 0 | 569,620 |
Nov 27 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Sell | 19.49 | 569,620 | 11,101,894 | 0 |
Nov 27 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 569,620 | 0 | 2,724,202 |
Nov 21 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Buy | 0.00 | 2,820,516 | 0 | 2,820,516 |
Nov 21 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Sell | 19.49 | 2,820,516 | 54,971,857 | 0 |
Nov 21 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 2,820,516 | 0 | 3,293,822 |
Nov 08 2017 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Sell | 0.00 | 1,000,000 | 0 | 2,256,013 |
Nov 08 2017 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Buy | 0.00 | 10,000 | 0 | 10,000 |
Nov 08 2017 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Sell | 0.00 | 10,000 | 0 | 0 |
Nov 08 2017 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Buy | 0.00 | 504 | 0 | 504 |
Nov 08 2017 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Buy | 0.00 | 2,302 | 0 | 2,302 |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTICALS, I ... | MOTT DAVID M | 10% Owner | Buy | 0.00 | 1,402,870 | 0 | 1,432,248 |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTICALS, I ... | MOTT DAVID M | 10% Owner | Buy | 0.00 | 2,927,708 | 0 | 4,359,956 |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTICALS, I ... | MOTT DAVID M | 10% Owner | Buy | 17.00 | 550,000 | 9,350,000 | 4,909,956 |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTICALS, I ... | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 1,402,870 | 0 | 0 |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTICALS, I ... | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 2,927,708 | 0 | 0 |
Sep 18 2017 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | 15.25 | 200,000 | 3,050,000 | 6,054,351 |
Aug 30 2017 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 3,394,439 | 0 | 3,818,940 |
Jul 06 2017 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 0.00 | 7,140,138 | 0 | 7,140,138 |
Jul 06 2017 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Buy | 15.00 | 1,000,000 | 15,000,000 | 8,140,138 |
Jul 06 2017 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 0.00 | 11,931,173 | 0 | 0 |
Jul 06 2017 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 0.00 | 18,001,419 | 0 | 0 |
Jul 06 2017 | MRSN | Mersana Therapeutics, Inc ... | MOTT DAVID M | Director | Option Exercise | 0.00 | 2,216,626 | 0 | 0 |
Jul 03 2017 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Option Exercise | 0.75 | 302,561 | 226,921 | 302,561 |
Jun 26 2017 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | 13.65 | 12,500 | 170,625 | 12,500 |
Jun 09 2017 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Buy | 0.00 | 19,534 | 0 | 33,877 |
Jun 09 2017 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Option Exercise | 4.30 | 15,000 | 64,500 | 15,000 |
Jun 05 2017 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | 0.00 | 676 | 0 | 12,825 |
Jun 05 2017 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | 149.22 | 12,000 | 1,790,640 | 12,000 |
May 31 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 6,114,338 | 0 | 0 |
May 31 2017 | APPN | APPIAN CORP | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 6,114,338 | 0 | 6,114,338 |
Mar 29 2017 | AVEO | AVEO PHARMACEUTICALS INC | MOTT DAVID M | 10% Owner | Buy | 0.50 | 6,000,000 | 3,000,000 | 16,362,694 |
Mar 28 2017 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Buy | 0.70 | 12,870,000 | 9,009,000 | 72,139,000 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Buy | 0.00 | 12,359,190 | 0 | 12,679,970 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Sell | 0.00 | 12,679,970 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Buy | 0.00 | 2,576,939 | 0 | 2,576,939 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Sell | 0.00 | 2,576,939 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Buy | 0.00 | 858,978 | 0 | 858,978 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Sell | 0.00 | 858,978 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 1,689,436 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 8,000,038 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 2,064,048 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 605,668 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 1,895,562 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 681,377 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 631,853 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 227,125 | 0 | 0 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 12,679,970 | 0 | 12,679,970 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 2,576,939 | 0 | 2,576,939 |
Mar 22 2017 | MULE | MULESOFT, INC | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 858,978 | 0 | 858,978 |
Dec 19 2016 | AKAO | Achaogen Inc | MOTT DAVID M | 10% Owner | Buy | 13.50 | 500,000 | 6,750,000 | 5,215,128 |
Nov 29 2016 | TCON | Tracon Pharmaceuticals, I ... | MOTT DAVID M | 10% Owner | Buy | 5.75 | 869,565 | 4,999,999 | 2,758,039 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.07 | 80,658 | 5,646 | 80,658 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Sell | 13.00 | 435 | 5,655 | 80,223 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 1,778,227 | 0 | 1,858,450 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 669,951 | 0 | 2,528,401 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Buy | 0.00 | 623,210 | 0 | 3,151,611 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Buy | 13.00 | 338,462 | 4,400,006 | 3,490,073 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.07 | 80,658 | 5,646 | 0 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 12,447,605 | 0 | 0 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 4,689,657 | 0 | 0 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.00 | 4,362,472 | 0 | 0 |
Sep 23 2016 | ROKA | Roka BioScience, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.70 | 4,000 | 2,800 | 4,000 |
Sep 23 2016 | ROKA | Roka BioScience, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 |
Aug 12 2016 | ADAP | Adaptimmune Therapeutics ... | MOTT DAVID M | Director | Option Exercise | 1.27 | 191,410 | 243,091 | 191,410 |